Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Inflammation plays a key role in male and female pattern hair loss, and focusing on this could help develop better treatments.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

A rare scalp disease causes hair loss, pus-filled nodules, and scarring.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Targeting Vδ1+T-cells may help treat alopecia areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecic and aseptic nodules of the scalp are rare, treatable, and often resolve with doxycycline or on their own.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Oral minoxidil can cause inflamed, ingrown hairs in the beard area.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Mast cells might contribute to hair loss by causing skin thickening.

A woman developed a scalp condition from using minoxidil, which improved with a different treatment but left scarring.